Drugs / Gelatin sponge
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT01527357 | May 2012 → Apr 2013 | — | Mallinckrodt | Completed | Met primary |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02762266 Comparator | Feb 2016 → Dec 2022 | hepatocellular carcinoma | Stanford University | Terminated | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gelatin sponge | “Gelatin sponge (gelfoam)” NCT02762266 ↗ |
| Known as | gelfoam | “Gelatin sponge (gelfoam)” NCT02762266 ↗ |
| Route | Topical | “Absorbable gelatin sponge for topical administration.” NCT01527357 ↗ |